Mood Disorders  >>  Mifeprex (mifepristone)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
ACTRN12606000253505: The treatment of depression in Parkinson's Disease using mifepristone.

Recruiting
3
20
 
Neurological Foundation, Neurological Foundation
Diagnostic and Statistical Manual 4th edition (DSM-IV) Major Depressive Episode in patients with Parkinson's Disease.
 
 
NCT00867360: Treatment of Psychotic Major Depression With Mifepristone

Terminated
3
10
US
Mifepristone (RU-486), Placebo
Stanford University
Affective Disorders, Psychotic, Depressive Disorder
05/09
05/09
NCT00725270: Treatment of Schizoaffective Disorder Using Mifepristone

Terminated
2/3
12
US
Mifepristone, Placebo Oral Tablet
Stanford University, Pritzker Family Foundation
Psychotic Disorders, Depressive Disorder, Major, Depressive Disorder
05/09
05/09

Download Options